Literature DB >> 22623246

The diagnosis and clinical importance of tumour neovascularisation from coronary artery to right atrial myxoma.

Sadik Acikel1, Ozlem Bozkaya, Ugursay Kiziltepe.   

Abstract

Myxomas are the commonest cardiac tumours and are usually localised in the atria. Neovascularisation in cardiac myxomas has been shown in previous case reports. However, the clinical importance of neovascularisation in cardiac myxomas is not well understood. In our case report, we present a right atrial myxoma in a 46 year-old woman admitted to our hospital with exertional angina and dyspnea. Coronary angiography revealed the presence of tumour neovascularisation from the right coronary artery, with no evidence of coronary artery stenosis. We thus speculate that neovascularisation of myxoma may cause typical anginal symptoms as a result of coronary steal phenomenon. Coronary angiography might help in the evaluation of the neovascularisation process and also in indicating surgery.

Entities:  

Mesh:

Year:  2012        PMID: 22623246

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN: 0022-9032            Impact factor:   3.108


  4 in total

Review 1.  How does knowledge of the blood supply to an intracardiac tumour help?

Authors:  Prabha Nini Gupta; Nishant Sagar; Ritesh Ramachandran; Velenurre Rajagopalan Rajeshekharan
Journal:  BMJ Case Rep       Date:  2019-02-25

2.  Giant left atrial myxoma with dual coronary supply presenting with recurrent stroke.

Authors:  A Akhundova; F Samedov; A Cincin; K Tigen; S Ispir; A R Ahiskali; I Sari
Journal:  Herz       Date:  2013-11-06       Impact factor: 1.443

Review 3.  The value of coronary angiography in the work-up of atrial myxomas.

Authors:  H R Omar
Journal:  Herz       Date:  2013-11-01       Impact factor: 1.443

4.  Right Ventricle Mass Induced Coronary Artery Steal Phenomenon: A Rare Clinical Manifestation on One Leiomyosarcoma Patient.

Authors:  Weng-Chio Tam; Ho-Shun Cheng; Cheng-Chih Chung; Ming-Hsiung Hsieh
Journal:  Acta Cardiol Sin       Date:  2015-09       Impact factor: 2.672

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.